Evidence map›Paper›PMID 25561519›Full record

ArticleGenome research2015

BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.

Guntram Borck, Friederike Hög, Maria Lisa Dentici, Perciliz L Tan, Nadine Sowada, Ana Medeira, Lucie Gueneau, Holger Thiele, Maria Kousi, Francesca Lepri and 15 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Genome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biallelic variants in GTF3C3 result in an autosomal recessive disorder with intellectual disability.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. RNA Polymerases I and III in development and disease.Seminars in cell & developmental biology · 2023
    Review
  17. Article
  18. Article
  19. tRNA dysregulation and disease.Nature reviews. Genetics · 2022
    Review
  20. One Host-Multiple Applications: Zebrafish (International journal of molecular sciences · 2022
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 7 countries.

Guntram BorckInstitute of Human Genetics, University of Ulm, 89081 Ulm, Germany; guntram.borck@uni-ulm.de.
Friederike HögGene Center Munich and Department of Biochemistry, Center for Integrated Protein Science CIPSM, Ludwig-Maximilians-Universität München, 81377 Munich, Germany;
Maria Lisa DenticiBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy;
Perciliz L TanCenter for Human Disease Modeling, Duke University, Durham, North Carolina 27710, USA;
Nadine SowadaInstitute of Human Genetics, University of Ulm, 89081 Ulm, Germany;
Ana MedeiraServiço de Genética, Departamento de Pediatria, Hospital S. Maria, CHLN, 1649-035 Lisboa, Portugal;
Lucie GueneauCenter for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland;
Holger ThieleCologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany;
Maria KousiCenter for Human Disease Modeling, Duke University, Durham, North Carolina 27710, USA;
Francesca LepriBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy;
Larissa WenzeckGene Center Munich and Department of Biochemistry, Center for Integrated Protein Science CIPSM, Ludwig-Maximilians-Universität München, 81377 Munich, Germany;
Ian BlumenthalMolecular Neurogenetics Unit and Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA;
Antonio RadicioniDepartment of Experimental Medicine, Sapienza University, 00161 Rome, Italy;
Tito Livio SchwarzenbergDepartment of Neonatology, Sapienza University, 00161 Rome, Italy;
Barbara MandrianiIRCCS Casa Sollievo Della Sofferenza, Medical Genetics Unit, 71013 San Giovanni Rotondo, Italy; PhD Program, Molecular Genetics applied to Medical Sciences, University of Brescia, 25121 Brescia, Italy;
Rita FischettoU.O. Malattie Metaboliche PO Giovanni XXIII, AOU Policlinico Consorziale, 70120 Bari, Italy;
Deborah J Morris-RosendahlGenomic Medicine, National Heart and Lung Institute, Imperial College, London SW3 6LY, United Kingdom;
Janine AltmüllerCologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany; Institute for Human Genetics, University of Cologne, 50931 Cologne, Germany;
Alexandre ReymondCenter for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland;
Peter NürnbergCologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50674 Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany;
Giuseppe MerlaIRCCS Casa Sollievo Della Sofferenza, Medical Genetics Unit, 71013 San Giovanni Rotondo, Italy;
Bruno DallapiccolaBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy;
Nicholas KatsanisCenter for Human Disease Modeling, Duke University, Durham, North Carolina 27710, USA;
Patrick CramerMax Planck Institute for Biophysical Chemistry, Department of Molecular Biology, 37077 Göttingen, Germany;
Christian KubischInstitute of Human Genetics, University of Ulm, 89081 Ulm, Germany; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Bambino Gesù Children's Hospital · ITDuke University · USUniversity of Cologne · DECasa Sollievo della Sofferenza · ITCenter for Integrated Protein Science Munich · DESapienza University of Rome · ITUniversität Ulm · DEUniversity of Lausanne · CHHarvard University · USHospital de Santa Maria · PTMax Planck Institute for Biophysical Chemistry · DENational Institutes of Health · USOspedale Pediatrico Giovanni XXIII · ITUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA polymerase III (Pol III) synthesizes tRNAs and other small noncoding RNAs to regulate protein synthesis. Dysregulation of Pol III transcription has been linked to cancer, and germline mutations in genes encoding Pol III subunits or tRNA processing factors cause neurogenetic disorders in humans, such as hypomyelinating leukodystrophies and pontocerebellar hypoplasia. Here we describe an autosomal recessive disorder characterized by cerebellar hypoplasia and intellectual disability, as well as facial dysmorphic features, short stature, microcephaly, and dental anomalies. Whole-exome sequencing revealed biallelic missense alterations of BRF1 in three families. In support of the pathogenic potential of the discovered alleles, suppression or CRISPR-mediated deletion of brf1 in zebrafish embryos recapitulated key neurodevelopmental phenotypes; in vivo complementation showed all four candidate mutations to be pathogenic in an apparent isoform-specific context. BRF1 associates with BDP1 and TBP to form the transcription factor IIIB (TFIIIB), which recruits Pol III to target genes. We show that disease-causing mutations reduce Brf1 occupancy at tRNA target genes in Saccharomyces cerevisiae and impair cell growth. Moreover, BRF1 mutations reduce Pol III-related transcription activity in vitro. Taken together, our data show that BRF1 mutations that reduce protein activity cause neurodevelopmental anomalies, suggesting that BRF1-mediated Pol III transcription is required for normal cerebellar and cognitive development.

Indexed as

MutationTranscription, GeneticAbnormalities, MultipleAdolescentAmino Acid SequenceAmino Acid SubstitutionAnimalsBrainCell ProliferationChildChild, PreschoolExomeFaciesFemaleHigh-Throughput Nucleotide SequencingHumansBRF1 protein, humanProtein IsoformsRNA Polymerase IIITATA-Binding Protein Associated Factors

Identifiers

PMID25561519
PMCPMC4315290
OpenAlexW2120644844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.